We are live on ! Find out more
QCG

Quadrant Capital Group Portfolio holdings

AUM $3.34B
1-Year Est. Return 29.16%
This Fund
S&P 500
This Quarter Est. Return
+6.38%
1 Year Est. Return
+29.16%
3 Year Est. Return
+77.72%
5 Year Est. Return
+92.59%
10 Year Est. Return
+303.92%
AUM
$1.01B
AUM Growth
+$47.4M
Cap. Flow
-$1.18M
Cap. Flow %
-0.12%
Top 10 Hldgs %
35.27%
Holding
2,824
New
110
Increased
1,008
Reduced
1,210
Closed
141

Sector Composition

Rank Sector Weight
1 Technology 15.36%
2 Healthcare 7.32%
3 Consumer Staples 7.12%
4 Financials 7.09%
5 Consumer Discretionary 6.05%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VRRM icon
1526
Verra Mobility
VRRM
$636M
$29.1K ﹤0.01%
1,476
+1,346
+1,035% +$23.8K
OPLN
1527
Openlane
OPLN
$4.25B
$29.1K ﹤0.01%
1,910
+1,821
+2,046% +$26.5K
ITOS
1528
DELISTED
iTeos Therapeutics
ITOS
$29K ﹤0.01%
2,194
+2,170
+9,042% +$30.9K
ICUI icon
1529
ICU Medical
ICUI
$4.04B
$29K ﹤0.01%
163
+36
+28% +$6.61K
HLIT icon
1530
Harmonic Inc
HLIT
$1.23B
$28.8K ﹤0.01%
1,781
+1,520
+582% +$24.4K
IART icon
1531
Integra LifeSciences
IART
$1.52B
$28.8K ﹤0.01%
699
-395
-36% -$19K
EYE icon
1532
National Vision
EYE
$1.66B
$28.7K ﹤0.01%
1,180
+996
+541% +$23.2K
HPP
1533
Hudson Pacific Properties
HPP
$794M
$28.6K ﹤0.01%
969
-2,084
-68% -$74.5K
VTRS icon
1534
Viatris
VTRS
$20.5B
$28.6K ﹤0.01%
2,868
+568
+25% +$5.42K
ONTF
1535
DELISTED
ON24
ONTF
$28.6K ﹤0.01%
3,517
-406
-10% -$3.37K
CCRN
1536
DELISTED
Cross Country Healthcare
CCRN
$28.6K ﹤0.01%
+1,017
New +$25.3K
CRC icon
1537
California Resources
CRC
$4.51B
$28.5K ﹤0.01%
+630
New +$25.6K
AKRO
1538
DELISTED
Akero Therapeutics
AKRO
$28.5K ﹤0.01%
611
MDRX
1539
DELISTED
Veradigm Inc. Common Stock
MDRX
$28.5K ﹤0.01%
2,263
+1,510
+201% +$18.3K
PEB icon
1540
Pebblebrook Hotel Trust
PEB
$2.19B
$28.4K ﹤0.01%
2,039
+566
+38% +$7.89K
NBR icon
1541
Nabors Industries
NBR
$1.16B
$28.4K ﹤0.01%
305
+201
+193% +$20.4K
NUVA
1542
DELISTED
NuVasive, Inc.
NUVA
$28.3K ﹤0.01%
681
+368
+118% +$15.1K
TWO
1543
Two Harbors Investment
TWO
$1.27B
$28.3K ﹤0.01%
2,039
+1,454
+249% +$19.2K
NOBL icon
1544
ProShares S&P 500 Dividend Aristocrats ETF
NOBL
$11.8B
$28.3K ﹤0.01%
600
RDN icon
1545
Radian Group
RDN
$5.18B
$28.2K ﹤0.01%
1,117
+64
+6% +$1.57K
HEI icon
1546
HEICO Corp
HEI
$49.9B
$28.1K ﹤0.01%
159
JOUT icon
1547
Johnson Outdoors
JOUT
$494M
$28.1K ﹤0.01%
457
-98
-18% -$5.86K
NRDY icon
1548
Nerdy
NRDY
$109M
$28.1K ﹤0.01%
6,734
CTBI icon
1549
Community Trust Bancorp
CTBI
$1.39B
$28.1K ﹤0.01%
789
-276
-26% -$9.93K
SBSW icon
1550
Sibanye-Stillwater
SBSW
$6.05B
$28K ﹤0.01%
4,492
+745
+20% +$5.88K

Similar funds

Quadrant Capital Group's Q2 2023 Portfolio in Review

As of Q2 2023, Quadrant Capital Group held 2,824 positions worth $1.01B, up 4.9% from $960M the previous quarter. Its ten largest holdings account for 35% of the portfolio.

Quadrant Capital Group's Q2 2023 filing shows 110 new, 1,008 increased, 1,210 reduced and 141 closed positions. Its largest new stake was Vanguard Total Bond Market: 4,133 shares worth $300K. The largest sale was Vanguard Short-Term Bond ETF, an estimated $3.76M.

By sector, the portfolio is most concentrated in Technology at 15% of assets, up from 14% a quarter earlier, followed by Healthcare and Consumer Staples.

  • Quadrant Capital Group's largest Q2 2023 buy was Vanguard Total Bond Market: 4,133 shares worth $300K.
  • Quadrant Capital Group added most to Procter & Gamble in Q2 2023, an estimated $13.6M increase.
  • Quadrant Capital Group's biggest Q2 2023 reduction was Vanguard Short-Term Bond ETF, cutting an estimated $3.76M.
  • Quadrant Capital Group fully exited ETRACS Alerian MLP Infrastructure Index ETN Series B due Apr 2 2040 in Q2 2023, selling an estimated $917K.
  • Quadrant Capital Group's ten largest holdings make up 35% of its $1.01B portfolio in Q2 2023.
  • Quadrant Capital Group opened 110 new positions and closed 141 in Q2 2023.
  • Quadrant Capital Group's portfolio value rose 4.9% quarter-over-quarter to $1.01B.

Based on Quadrant Capital Group's 13F filing for Q2 2023, filed 10 Aug 2023.